Sirolimus/Tacrolimus Facilitates Preferential Recovery of Regulatory T Cells (Treg) After Allogeneic Hematopoietic Cell Transplantation (HCT), and Is More Effective Than Methotrexate/Tacrolimus in Preventing Grade II-IV Acute Graft Vs. Host Disease (GVHD) and Moderate to Severe Chronic Gvhd
暂无分享,去创建一个
H. Jim | J. Perkins | J. Pidala | Jongphil Kim | L. Ochoa | C. Anasetti | F. Locke | H. Fernandez | W. Janssen | M. Kharfan-Dabaja | T. Nishihori | M. Alsina | E. Ayala | L. Perez | M. Tomblyn | B. Betts | T. Field | Mian Xu